TCM

Tang Capital Management Portfolio holdings

AUM $1.98B
This Quarter Return
-17.36%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$712M
AUM Growth
+$712M
Cap. Flow
+$68.1M
Cap. Flow %
9.56%
Top 10 Hldgs %
91.51%
Holding
30
New
13
Increased
4
Reduced
2
Closed
5

Top Buys

1
BIO icon
Bio-Rad Laboratories Class A
BIO
$28M
2
UTHR icon
United Therapeutics
UTHR
$19.8M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
$13.2M
4
SGMO icon
Sangamo Therapeutics
SGMO
$12.9M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
$11.8M

Top Sells

1
HRTX icon
Heron Therapeutics
HRTX
$24.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
$16.9M
3
BMY icon
Bristol-Myers Squibb
BMY
$7.18M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$2.15M
5
NCNA
NuCana
NCNA
$875K

Sector Composition

1 Healthcare 98.74%
2 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$389M 54.57% 14,075,269 – –
RLMD icon
2
Relmada Therapeutics
RLMD
$37.2M
$44.3M 6.23% 1,300,000 – –
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$354M
$41.4M 5.81% 2,965,485 – –
HRTX icon
4
Heron Therapeutics
HRTX
$207M
$34M 4.78% 2,896,904 -2,120,299 -42% -$24.9M
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
$33.9M 4.77% 8,080,345 +3,141,452 +64% +$13.2M
ANAB icon
6
AnaptysBio
ANAB
$569M
$32.4M 4.55% 2,290,827 +447,013 +24% +$6.32M
BIO icon
7
Bio-Rad Laboratories Class A
BIO
$8.06B
$28M 3.94% +80,000 New +$28M
UTHR icon
8
United Therapeutics
UTHR
$13.8B
$19.8M 2.78% +208,415 New +$19.8M
TECX
9
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$15.6M 2.18% 1,000,000 – –
EOLS icon
10
Evolus
EOLS
$494M
$13.7M 1.92% 3,295,000 +660,000 +25% +$2.74M
SGMO icon
11
Sangamo Therapeutics
SGMO
$157M
$13M 1.82% +2,032,980 New +$12.9M
EGRX
12
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$11.8M 1.65% +255,616 New +$11.8M
PBYI icon
13
Puma Biotechnology
PBYI
$254M
$6.75M 0.95% 800,000 +450,600 +129% +$3.8M
CHRS icon
14
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$5.68M 0.8% +350,000 New +$5.68M
LSACU
15
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
$5M 0.7% +500,000 New +$5M
PRTA icon
16
Prothena Corp
PRTA
$441M
$4.54M 0.64% 423,823 – –
RDUS
17
DELISTED
Radius Health, Inc.
RDUS
$3.9M 0.55% +300,000 New +$3.9M
VNDA icon
18
Vanda Pharmaceuticals
VNDA
$279M
$3.11M 0.44% +299,800 New +$3.11M
CTMX icon
19
CytomX Therapeutics
CTMX
$336M
$2.3M 0.32% +300,000 New +$2.3M
GTHX
20
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.87M 0.26% 170,000 – –
ENTA icon
21
Enanta Pharmaceuticals
ENTA
$180M
$693K 0.1% +13,483 New +$693K
ITCI
22
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$637K 0.09% +41,444 New +$637K
CMRX
23
DELISTED
Chimerix, Inc.
CMRX
$621K 0.09% +431,273 New +$621K
NCNA
24
NuCana
NCNA
$6.09M
$583K 0.08% 100,000 -150,000 -60% -$875K
UPS icon
25
United Parcel Service
UPS
$74.1B
$93K 0.01% +1,000 New +$93K
1
2